Analyst	Recommendation	Action	Price target	Projected	Date
Douglas Tsao H.C. Wainwright	Buy	Reiterated	$7.00	+607.1%	09/21/2026
Jason McCarthy Maxim Group	Buy	Maintained	$4.00	+304%	08/06/2026
Paul Jeng Guggenheim	Buy	Maintained	$10.00	+910.1%	08/06/2026
Jay Olson Oppenheimer	Buy	Maintained	$10.00	+910.1%	08/06/2026
Michael Nedelcovych TD Cowen	Buy	Maintained	-	-	05/28/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	11.57M	12.75M	12.31M	14.31M
Cost of goods sold	3.72M	4.04M	3.81M	4.24M
Cost of revenue	3.72M	4.04M	3.81M	4.24M
Research and development expenses	27.25M	30.97M	21.54M	21.45M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	22.83M	21.01M	23.10M	20.95M
Operating expense	50.08M	51.98M	44.65M	42.40M
Total operating expenses	53.80M	56.03M	48.46M	46.64M
Operating income	-42.23M	-43.28M	-36.15M	-32.33M
Other non operating income	2.14M	-5.22M	1.40M	1.31M
EBT including unusual items	-44.52M	-46.35M	-36.94M	-33.35M
EBT excluding unusual items	-42.42M	-43.75M	-36.94M	-33.35M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-35.53M	-37.64M	-38.33M	-20.63M
Net profit margin	-307.07%	-295.29%	-311.35%	-144.20%
Earnings per share	-0.33	-0.34	-0.25	-0.19
Interest and investment income	-	7.00M	-	-
Interest expense	-2.32M	-2.25M	-2.19M	-2.32M
Net interest expenses	-2.32M	4.75M	-2.19M	-2.32M
Depreciation and amortization charges	-	-	-	-
EBITDA	-41.27M	-42.38M	-35.27M	-31.47M
Gain or loss from assets sale	-	-338.32M	-	-

Ask anything